RxDoctor Payments Data

William Hughes, MD

Family Medicine · Fayetteville, TNNPI 1497862999

Payments from drug & device makers

$10,226in general payments, 2019–2025

Across 671 payments — averaging $15.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • Amgen$1K
  • Lilly USA, LLC$523
  • Merck$504
  • AstraZeneca$467
  • plus $5K from 39 others

What the payments were for

  • Food & beverage$10,218100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,226 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$106,719
Medicare patients
257
Services billed
2,294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide117$164,951
Cosentyx Unoready PenSecukinumab11$83,944
EliquisApixaban93$67,389
FarxigaDapagliflozin Propanediol72$54,862
MounjaroTirzepatide42$44,686
Breztri AerosphereBudesonide/Glycopyr/Formoterol55$35,844
Tresiba Flextouch U-200Insulin Degludec25$35,021
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$33,076
TrulicityDulaglutide24$31,764
XareltoRivaroxaban37$29,462
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog22$24,984
JanuviaSitagliptin Phosphate22$24,625
MyrbetriqMirabegron34$23,761
LinzessLinaclotide32$21,020
JardianceEmpagliflozin17$20,531

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,623$164,951117 claims
AstraZenecaFarxiga, Breztri Aerosphere, Nexium$467$96,178146 claims
Lilly USA, LLCMounjaro, Trulicity$523$76,45066 claims
PfizerEliquis, Abrysvo$404$74,948117 claims
GSKTrelegy Ellipta, Shingrix, Breo Ellipta$40$44,74394 claims
Johnson & JohnsonXarelto$270$29,46237 claims
MerckJanuvia$504$24,62522 claims
AbbVieLinzess, Synthroid$1,153$24,59882 claims
Astellas Pharma US IncMyrbetriq$294$23,76134 claims
Boehringer IngelheimJardiance$362$20,53117 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$201$16,81811 claims
NovartisEntresto$292$11,03915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Fayetteville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →